百克生物

新闻

相关新闻

  1. Luzhu's major products are currently in the research and development stage and it does not have any approved products for sale, and has suffered a loss of over 1.5 billion yuan in the past three years.
    快讯：绿竹生物启动股份回购
    2480.HK
  2. 盛禾生物将上市 传闻筹资额大减
  3. 涂鸦智能亏损收窄 股价仍存一定风险                       
    2391.HK
  4. 声通科技具潜力 盈利恢复可期
  5. 中国好声音陨落 星空华文困局难解
    6698.HK
  6. 新药接连披露数据 康方生物坐过山车
    9926.HK
掌握中概股最新动态，订阅我们的新闻邮件

关注我们

Facebook Twitter Linkedin Weixin Weibo Youtube

免费订阅新闻邮件

订阅邮件

在以下平台浏览我们的新闻

factiva